14 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
10 Jan 22
Regulation FD Disclosure
8:17am
strain (Kuykendall) Targets ICAM expressing tumors Indications Patient Samples Tested (N) ICAM+ Prevalence NSCLC 97 72% HCC 69 72% RCC 67 79% Note … vRNA encoding for the synthetic Seneca Valley Virus (SVV) Targets SCLC & neuroendocrine prostate Induces tumor regression & improves survival
10-K
etjnfratdp
10 Mar 21
Annual report
4:12pm
424B4
q0jaqot86sw0onqm62c
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
a9cvb28v5b
28 Jan 21
Draft registration statement
12:00am
424B4
k3aqcw8
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
ej1pe3khoetv
11 Sep 20
IPO registration
4:49pm
CORRESP
r42l2fm 4q1y
11 Sep 20
Correspondence with SEC
12:00am
DRS/A
g73e krlp9tszy1fs7p
26 Aug 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next